GL1X · GenesisL1 explorer

MolNFT v1 · #188644 · protein

Structure of SARS-cov-2 mpro lambda (G15S) in complex with nirmatrelvir (pf-07321332)

7U28 · 3C-like proteinase NSP5: “Structure of SARS-cov-2 mpro lambda (G15S) in complex with nirmatrelvir (pf-07321332)”. X-ray diffraction, 1 ligand (4WI), 7 pockets (best druggability 0.75). MolNFT v1 #188644 on GenesisL1: 3D structure…

PDB
7U28
Type
protein
Length
604 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase NSP5
EC
3.4.22.69
UniProt
P0DTC1
Ligands
4WI
Pockets
7 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinase NSP5 (EC 3.4.22.69)protein30226% helix, 29% strandP0DTC1

Ligands and binding sites

  • 4WI · (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18980.750.7976empty
22040.540.78274WI
32520.530.7634empty
42040.530.77294WI
51950.460.7425empty

Interfaces

1 interface between chains.

  • A–B · 1344 Ų buried · 32 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7U28 · Structure of SARS-CoV-2 Mpro Lambda (G15S) in complex with Nirmatrelvir (PF-07321332) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.